Best NAD+ Injection Providers Online (2026)
NAD+ supplementation has become one of the most-discussed longevity therapies, with mechanistic support from the Garten et al. 2015 review (Cell Metabolism) and early human data from the Elhassan et al. 2019 RCT (Cell Reports Medicine). This ranking lists only providers with a supplied destination specifically mapped to an NAD+ offer, then compares dose flexibility, fulfillment context, and clinician oversight.
Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to mitochondrial energy metabolism and DNA repair. Preclinical research has established that NAD+ levels decline with age and that restoring them extends healthspan in animal models. Human data are more limited: the Elhassan et al. 2019 RCT (Cell Reports Medicine) demonstrated that oral NMN supplementation raises blood NAD+ levels in healthy adults, and several small trials have shown subjective improvements in energy and cognitive function with IV or intramuscular NAD+.
Online NAD+ providers vary significantly in delivery route (IV infusion, intramuscular injection, nasal spray, or oral supplement), dose, and pharmacy quality. Injectable protocols dispensed by licensed 503A or 503B pharmacies carry the strongest bioavailability argument; oral NMN and NR supplements are more accessible but have lower and more variable bioavailability. The best providers disclose their pharmacy partner, offer dose flexibility, and include a licensed prescriber in the protocol.
We include a provider in this ranking only when its supplied affiliate destination is mapped to an NAD+ offer. We then compare the eligible providers on dose options, route variety, pharmacy licensure, and transparent program terms.
The Ranking
AgelessRx
Longevity-focused clinic with à la carte access to rapamycin, NAD+, LDN, and metformin protocols.
Editor’s take: The clearest pick when you specifically want rapamycin, LDN, or metformin from a longevity-native clinic. Buyers focused on weight loss alone should look at a dedicated GLP-1 specialist.
Full review →
Doctor-prescribed peptide clinic offering CJC-1295, tesamorelin, MOTS-c, NAD+, and glutathione from a licensed US pharmacy.
Editor’s take: A peptide-native telehealth option with individual treatment pages for its active protocols. Readers focused on GLP-1 weight loss should compare providers with a valid category-matched GLP-1 offer instead.
Full review →
ReadyRx
Multi-protocol longevity and metabolic health platform offering GLP-1s, NAD+, sermorelin, and glutathione with doctor-led plans and peer community support.
Editor’s take: A well-rounded longevity and metabolic health platform with competitive all-inclusive pricing. The breadth of protocols (GLP-1, NAD+, sermorelin, glutathione) and the peer community make it a strong choice for patients who want more than just a GLP-1 prescription.
Full review →
RNK Health
Longevity-first clinic that bundles GLP-1, peptides, and enclomiphene into one healthspan program.
Editor’s take: A healthspan-flavoured clinic with an unusually broad menu for the price. Less of a fit if you only want a single-prescription transactional experience. If you only want a single-prescription program at the lowest possible cost, a specialist like Trimi or MangoRx will be more cost-effective than RNK's multi-protocol approach.
Full review →
Premium GLP-1 clinic with a needle-free sublingual semaglutide tablet option.
Editor’s take: A premium-priced clinic that earns its rate through the sublingual tablet option and unlimited messaging. Most buyers can find compounded injections cheaper elsewhere. Most buyers can find compounded GLP-1 for less elsewhere; Willow's premium is justified primarily by the sublingual tablet option and the unlimited messaging model.
Full review →
Oak Longevity
Affordable compounded GLP-1 with no hidden membership fees, plus longevity peptides.
Editor’s take: A reasonable lower-cost combined GLP-1 + longevity option. The flat per-medication pricing with no membership fee and free shipping is genuinely competitive. The main limitation is brand maturity — Oak Longevity has fewer public reviews than Eden or Telos Rx. If established brand recognition matters, look at Eden; if you want the lowest all-in cost for GLP-1 + peptides, Oak is worth a closer look.
Full review →
HealthRx
LegitScript-certified compounded GLP-1 clinic with flat dose pricing — semaglutide from $99/mo and tirzepatide from $149/mo on annual plans, plus ED, hair, and longevity add-ons.
Editor’s take: A clean, transparent GLP-1 clinic with competitive annual-plan pricing and a genuine money-back guarantee on unapproved consultations. The LegitScript certification and named 503A pharmacy (USP-797 sterile standards) add credibility. Best price requires a 12-month commitment; month-to-month rates are higher. No brand-name medications and limited public review history given its 2024 founding.
Full review →
TMates
Flat-rate compounded GLP-1s plus brand-name Wegovy and Zepbound, with all dosages priced the same.
Editor’s take: If predictable, dose-flat pricing matters more to you than a deeply specialised clinic experience, TMates earns its place on the shortlist. Look elsewhere if you want a hands-on, high-touch provider relationship.
Full review →
Pallas Health
Online GLP-1 and NAD+ care with bundled provider support, a $139 compounded-semaglutide first month, and a dedicated NAD+ program.
Editor’s take: Pallas Health combines a polished bundled-care GLP-1 program with an uncommon NAD+ offering. It earns credit for stating its introductory and renewal pricing clearly, including the 12-week renewal cadence, and for listing both compounded and FDA-approved options. The headline introductory rate is not the long-term average, however, and the program is private pay. Consider Pallas if you value ongoing provider support, free shipping and the option to explore NAD+ alongside weight management; confirm the exact medication, quarterly renewal amount and state-specific visit requirements before enrolling.
Full review →
Clinician-led online longevity care with published NAD+ and sermorelin starting rates from $27 per week.
Editor’s take: Luvo is a longevity-focused telehealth comparison option with public $27 weekly starting prices for its reviewed NAD+ and Sermorelin pages. That transparency makes it worth comparing, but the price should be treated as a weekly starting figure rather than a universal monthly all-in commitment. The provider’s clinician-led process and listed treatment menu do not establish that any particular medication is appropriate for an individual. Ask about the exact prescription, evidence base, compounded-product status, monitoring, pharmacy and full payment schedule before enrolling.
Full review →2026 Price Comparison. All-In Monthly Cost
Prices verified June 2026· How we verify →Published monthly price terms at the lowest listed rate and higher listed rate. Read each provider’s terms note because medication, consult, shipping, and plan-length conditions vary.
Prices are verified from public provider websites and may change. Compounded medications are from 503A pharmacies operating under personalisation exceptions. Always confirm pricing and legal status directly with the provider before purchase.
| Provider | Starting dose | Maintenance dose | Pharmacy | Trustpilot | Verified | Actions |
|---|---|---|---|---|---|---|
AgelessRxBest Value | $25/mo | $149/mo | 503A | 4.4 | June 2026 | |
3-month programs | $66/mo | $199/mo | 503A | 4.5 | June 2026 | |
NAD+ injection: $89 first month, then $597 every 12 weeks ($199/mo average); nasal spray also available | $89/mo | $199/mo | US-licensed pharmacy | — | Aug 15 | |
12-mo plan; $133/mo on 3-mo plan | $99/mo | $133/mo | 503A | — | Jul 18 | |
| $130/mo | $299/mo | 503A | 4.6 | June 2026 |
- Starting dose
- $25/mo
- Maintenance dose
- $149/mo
- Pharmacy
- 503A
- Price checked
- June 2026
3-month programs
- Starting dose
- $66/mo
- Maintenance dose
- $199/mo
- Pharmacy
- 503A
- Price checked
- June 2026
NAD+ injection: $89 first month, then $597 every 12 weeks ($199/mo average); nasal spray also available
- Starting dose
- $89/mo
- Maintenance dose
- $199/mo
- Pharmacy
- US-licensed pharmacy
- Price checked
- Aug 15
12-mo plan; $133/mo on 3-mo plan
- Starting dose
- $99/mo
- Maintenance dose
- $133/mo
- Pharmacy
- 503A
- Price checked
- Jul 18
- Starting dose
- $130/mo
- Maintenance dose
- $299/mo
- Pharmacy
- 503A
- Price checked
- June 2026
All prices are all-in (consult + medication + shipping) unless noted. Prices verified June 2026. Compounded medications are not FDA-approved finished products. They are compounded under 503A personalisation exceptions. Click any provider name to read the full independent review. CTA buttons link to provider websites and may earn us a commission. How we verify prices →
Methodology
Scored on dose options, route variety (injection vs nasal), pharmacy licensure, and bundling with adjacent peptides.
NAD+ Therapy Online: What the Evidence Actually Supports
NAD+ (nicotinamide adenine dinucleotide) has become one of the most marketed longevity interventions in telehealth. The science is genuinely interesting — and the gap between the science and the marketing is genuinely large. Here is an honest read of where the evidence stands.
What NAD+ Does in the Body
NAD+ is a coenzyme involved in cellular energy metabolism and DNA repair. It declines with age — by approximately 50% between ages 40 and 60 in some tissues. Preclinical studies in mice have shown that restoring NAD+ levels can extend healthspan, improve mitochondrial function, and reduce markers of metabolic dysfunction.
The preclinical data is compelling. The human clinical data is much thinner. Most human trials of NAD+ precursors (NMN, NR) have been small, short-duration, and focused on biomarker endpoints rather than clinical outcomes. No large randomized trial has demonstrated that NAD+ supplementation extends human lifespan or prevents age-related disease.
IV vs Subcutaneous vs Oral: Does Route Matter?
IV NAD+ infusions produce a rapid rise in plasma NAD+ but are expensive ($200–$800 per session), require in-person or supervised administration, and have not been shown to produce superior clinical outcomes compared to oral precursors. Subcutaneous injections of NMN or NAD+ are offered by telehealth longevity clinics as a middle ground — more bioavailable than oral, less expensive than IV.
Oral NMN and NR raise blood NAD+ levels in humans — that is established. Whether those elevated levels translate to meaningful clinical benefit in healthy adults is not established. The honest answer from the current literature is: we don't know yet.
Who Is a Reasonable Candidate
NAD+ therapy is most defensible for adults over 50 with documented metabolic dysfunction, fatigue, or cognitive concerns who have already addressed the basics (sleep, exercise, diet, cardiovascular risk). For younger adults without specific concerns, the cost-benefit is harder to justify given the current evidence base.
A serious longevity clinic will frame NAD+ as one component of a broader protocol — not a standalone intervention — and will be honest about the limits of the human evidence. Clinics that promise specific outcomes (energy, cognition, anti-aging) without citing clinical trial data are overstating what the science supports.
NAD+ therapy is a reasonable experiment for adults who understand the evidence limitations and can afford the cost. It is not a proven longevity intervention in humans. The clinics in our top tier above are honest about that distinction.
What the Studies Actually Show
NAD+ supplementation is a longevity protocol with mechanistic plausibility but limited human RCT evidence for hard clinical endpoints. Injectable / nasal NAD+ products are not FDA-approved drugs; they are dispensed via 503A or 503B compounding. The figures below summarise the published evidence base, including the conservative read on injectable formulations.
| Endpoint | Finding |
|---|---|
| Mechanism (Rajman et al. 2018)1 | NAD+ is a coenzyme central to mitochondrial energy metabolism, sirtuin activation, and DNA-repair pathways. NAD+ levels decline with age in human tissues |
| Oral precursors — NR / NMN human RCTs2 | Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) reliably raise blood NAD+ levels by 1.5–2x in randomized trials. Downstream clinical endpoints (insulin sensitivity, exercise capacity, biological age markers) have shown mixed and often modest results Injectable / nasal NAD+ products are not FDA-approved drugs. Most U.S. providers compound them through 503A or 503B pharmacies. Quality of evidence for the injectable route is materially weaker than for oral precursors. |
| Safety profile (oral precursors, RCT pooled data)2 | Oral NR and NMN appear well tolerated up to 1,000 mg/day for 12 weeks in healthy adults. GI upset is the most common adverse event |
Frequently Asked Questions
- Rajman L et al. — Cell Metabolism 2018 · Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab 2018;27(3):529–547.
- NR/NMN Clinical Trials — Frontiers in Aging 2022 · Reiten OK, Wilvang MA, Mitchell SJ, Hu Z, Fang EF. Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing. Mech Ageing Dev 2021;199:111567.
RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.